New members

Welcome New Corporate Member: Universal Cells

Universal Cells commercializes stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using its proprietary gene editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyte antigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient. This approach avoids the limitations of current allogeneic and autologous cell therapies, as it creates off-the-shelf therapies, with no need for matching of donor cells or for immunosuppression.

Learn more on their website: 

Share this page Share on FacebookShare on TwitterShare on Linkedin


COVID-19 Updates